NASDAQ: SMTI - Sanara MedTech Inc.

Rentabilität für sechs Monate: -0.0661%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Sanara MedTech Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Sanara MedTech Inc.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States.

weitere details
It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2011-02-22
ISIN US79957L1008
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://sanaramedtech.com
Цена ао 29.63
Preisänderung pro Tag: -3.2% (31.22)
Preisänderung pro Woche: -10.06% (33.6)
Preisänderung pro Monat: -15.11% (35.6)
Preisänderung über 3 Monate: -9.79% (33.5)
Preisänderung über sechs Monate: -0.0661% (30.24)
Preisänderung pro Jahr: -18.32% (37)
Preisänderung über 3 Jahre: +5.89% (28.54)
Preisänderung über 5 Jahre: +182.43% (10.7)
Preisänderung seit Jahresbeginn: -10.27% (33.68)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 4.88 3
P/BV 7.11 1
P/E 0 0
EV/EBITDA -81.07 0
Gesamt: 2.25

Effizienz

Name Bedeutung Grad
ROA, % -5.83 0
ROE, % -9.6 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0.2329

Pflicht

Name Bedeutung Grad
Debt/EBITDA -2.52 10
Gesamt: 8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 450.76 10
Rentabilität Ebitda, % -88.44 0
Rentabilität EPS, % -36.66 0
Gesamt: 3.2
Weitere Details

Institutionen Volumen Aktie, %
Blackrock Inc. 204745 3.27
Vanguard Group Inc 140046 2.24
Geode Capital Management, LLC 74682 1.19
State Street Corporation 53399 0.85
Northern Trust Corporation 30906 0.49
Ameriprise Financial, Inc. 16030 0.26
Janney Montgomery Scott LLC 15369 0.25
Bank Of New York Mellon Corporation 14170 0.23
Diametric Capital, LP 13607 0.22
Salem Investment Counselors, Inc. 11210 0.18

ETFAktie, %Rentabilität für das Jahr, %Dividenden, %
iShares Micro-Cap ETF 0.03246 17.09 1.54048
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02292 31.36 1.41955
WisdomTree U.S. SmallCap Fund 0.01751 15.03 1.80258
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
iShares Russell 2000 Growth ETF 0.00951 38.04 0.6026
ProShares UltraPro Russell2000 0.00277 89.82 1.47873
ProShares Hedge Replication ETF 0.00077 5.92 1.47892
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.0129.931.32



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Ronald T. Nixon Executive Chairman & CEO N/A 1956 (69 Jahre)
Mr. Michael D. McNeil CFO & Corporate Secretary 438.68k 1965 (60 Jahre)
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. President of Telehealth Services 156k 1970 (55 Jahre)
Mr. Callon Nichols Vice President of Corporate Operations N/A
Mr. Bill Fitzgerald Chief Compliance Officer N/A
Ms. Tricia Matteson Vice President of Marketing N/A
Dr. Rebecca Erin Mcmahon President of Research & Development N/A 1985 (40 Jahre)
Mr. Seth Yon President of Commercial N/A
Mr. Jacob A. Waldrop Chief Operating Officer
Mr. Tyler Palmer Chief Corporate Development & Strategy Officer

Adresse: United States, Fort Worth. TX, 1200 Summit Avenue - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://sanaramedtech.com